New combo antibody therapy may be beneficial for IBD patients who are not responding to treatment
More than 4.9 million people worldwide are thought to suffer from inflammatory bowel disease (IBD), which is a catch-all name for ulcerative colitis (UC) and Crohn’s disease, two disorders that…